PharmaMar

Trial Results: Oncology

Wednesday, October 1, 2008

PharmaMar reported positive results from a phase III trial of Yondelis for the treatment of ovarian cancer. This randomized study enrolled 627 women with ovarian cancer who had relapsed after receiving standard first-line chemotherapy, across several international sites.

[Read More]